A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: A subgroup analysis of senile patients

Chinese Journal of Integrative Medicine

Volumn 17, Issue 9, 2011, Pages 669-674

  Shang, Qing Hua ^a   Xu, Hao ^b   Lu, Xiao Yan ^b   Wen, Chuan ^b   Shi, Da Zhuo ^c   Chen, Ke Ji ^c  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c XIYUAN HOSPITAL   (China)

Author keywords

Active blood circulation; Coronary heart disease; Percutaneous coronary intervention; Restenosis; Senile; Xiongshao Capsule

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; CHINESE DRUG; CHUANGXIONGOL; CREATININE; DILTIAZEM; GLYCERYL TRINITRATE; NITROGEN; PAEONIFLORIN; PLACEBO; TERPENOID DERIVATIVE; TICLOPIDINE; UNCLASSIFIED DRUG; XIONGSHAO; HERBACEOUS AGENT;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; BIOASSAY; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MICROCAPSULE; RADIOGRAPHY; RECURRENT DISEASE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; CAPSULES; CHINA; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; PLACEBOS; RECURRENCE;

EID: 84862833199     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-011-0843-7     Document Type: Article

References (14)

1. Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, et al. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents. Am J Cardiol 2009;104:1362-1369.
2. Xu H, Shi DZ, Chen KJ, Ma XC, Li YL, Meng L, et al. Effect of Xiongshao Capsule on vascular remodeling in porcine coronary balloon injury model. Chin J Integr Tradit West Med (Chin) 2001;21:591-594.
3. Xu H, Shi DZ, Chen KJ, Wang JH, Ma XC. Effect of Xiongshao Capsule on proliferation and apoptosis of vascular smooth muscle cells in rabbits observed by serum pharmacological method. Chin J Integr Tradit West Med (Chin) 2000;20:757-760.
4. Xu H, Shi DZ, Chen KJ, Ma XC, Mao JM, Lv SZ, et al. Clinical effect of Xiongshao Capsule on preventing restenosis post-PTCA or/and stenting. Chin J Integr Tradit West Med (Chin) 2000;20:494-497.
5. Xu H, Shi DZ, Chen KJ, Ma XC, Li YL, Meng L, et al. Effect of XS0601 on apoptosis and gene expression of p53 and bcl-2 in neointima of porcine coronary artery after balloon injury. Chin J Intervent Cardiol (Chin) 2001;9:152-154.
6. Xu H, Chen KJ, Shi DZ, Ma XC, Lv SZ, Mao JM. Clinical study of Xiongshao Capsule in preventing restenosis after coronary interventional treatment. Chin J Integr Med 2002; 8: 162-166.
7. Chen KJ, Shi DZ, Xu H, Lv SZ, Li TC, Ke YN, et al. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China. Chin Med J 2006; 119: 6-13.
8. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979;59;607-609.
9. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB 3rd, Loop FD, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988;78:486-502.
10. Maisel WH. Unanswered questions - drug-eluting stents and the risk of late thrombosis. NEJM 2007;356:981-984.
11. Curfman GD, Morrissey S, Jarcho JA, et al. Drug-eluting coronary stents - promise and uncertainty. NEJM 2007;356:1059-1060.
12. Shi DZ, Li Jing, Ma XC, Zhang QH, Mao JM, Chen MZ, et al. Clinical observation of concentrated Xuefu Zhuyu Pill in preventing restenosis of patients with coronary heart disease after percutaneous transluminal coronary angioplasty. J TCM (Chin) 1997;38:27-29.
13. Yu B, Chen KJ, Mao JM. Clinical study on effect of Concentrated Xuefu Zhuyu Pill on restenosis of 43 cases coronary heart disease after intracoronary stenting. Chin J Integr Tradit West Med (Chin) 1998;18:585-589.
14. Xu H, Gao ZY, Chen KJ. A prospective study on the diagnositic and therapeutic status and prognosis of the 1864 elderly patients with coronary heart disease. Chin J Geriatr (Chin) 2008;27:617-622.